4-Isopropyl-Thiazole-2-Carboxylic Acid, Min. 95 %

Conversion of 4-isopropylthiazole-2-carboxylic acid (min. 95 % assay) into the corresponding acyl chloride initiates one of the most stringent reaction sequences observed in pharmaceutical intermediate production. Charged into a glass-lined stirred tank equipped with a reflux condenser and caustic scrubber, the acid is suspended in 2.5 volumes of anhydrous toluene adjusted to a water content below 50 ppm by Karl Fischer titration (ASTM E203). Thionyl chloride (1.15 molar equivalents) is metered at a rate that maintains the internal temperature between −2 °C and +3 °C; deviation beyond +5 °C triggers a detectable decarboxylation pathway releasing CO₂ and forming 4-isopropylthiazole as a volatile impurity, which must be purged before the subsequent coupling step. Once the addition is complete, the batch is heated to 45 °C for 90 minutes, then stripped under reduced pressure (40 mbar, jacket 55 °C) to scavenge residual SO₂ and HCl. The resulting dark oil is used immediately—holding the isolated acyl chloride longer than 6 hours at 5 °C leads to measurable dimerization via anhydride formation, confirmed by LC-MS adduct peaks at m/z 341.

Subsequent coupling with sterically hindered aromatic amines, such as 4-(2,4-difluorophenyl)piperidine, is executed in anhydrous tetrahydrofuran spiked with 1.05 equivalents of triethylamine. The amine component is pre-dried by azeotropic distillation with toluene to a water specification of <100 µg/g. The addition sequence is inverted—acyl chloride solution is added to the amine base at −10 °C—to suppress ketene formation and maintain chemoselectivity toward the amide over the ester byproduct. After 12 hours at room temperature, the reaction mixture is quenched with 5 % w/w aqueous citric acid, phase-separated, and the organic layer washed with 2 % NaHCO₃ until the aqueous phase conductivity drops below 200 µS/cm. The crude carboxamide is isolated by solvent swap into n-heptane, seed-crystallized at −5 °C, and dried in a double-cone vacuum dryer (40 °C, 10 mbar) to reach residual THF below 720 ppm per USP <467> Class 2 residual solvent limits.

Regulatory compliance for the resulting intermediate follows ICH Q7 for active pharmaceutical ingredient starting materials, with batch records traceable to the acid lot certificate of analysis. A dedicated purity panel verifies the carboxamide content by HPLC (area normalization at 254 nm, C18 column, acetonitrile/0.1 % H₃PO₄ gradient) against a working standard calibrated by qNMR. Any single unspecified impurity exceeding 0.10 % triggers an impurity fate and purge study anchored to the proposed synthesis of a kinase-targeted trisubstituted thiazole lead series—often progressed through solid form screening to a hydrochloride salt exhibiting a melting endotherm onset at 189–193 °C by DSC (ASTM E967). The terminal drug substance, a selective tyrosine kinase inhibitor candidate, is isolated as a monohydrate with water content 3.8–4.2 % w/w, and its photostability is assessed under ICH Q1B Option 2 conditions with confirmatory LC-PDA peak purity analysis.

The major processing bottleneck observed on multi-kilogram campaigns stems from the narrow thermal window during acid chloride formation: a jacket chiller failure at the site in Jiangsu in 2022 reportedly caused a batch temperature excursion to 9 °C, elevating the decarboxylation impurity to 2.1 % and necessitating a costly re-purification by fractional crystallization from ethyl acetate/cyclohexane. Site-specific preventive measures now include redundant recirculating chillers with a ±1 °C control band and continuous in-situ FTIR monitoring of the carbonyl stretch at 1792 cm⁻¹ to track anhydride accumulation in real time.

The transformation of 4-isopropylthiazole-2-carboxylic acid into a functionalized agrochemical intermediate typically bypasses the isolated acyl chloride stage when deploying a one-pot phosphoric acid anhydride activation (T3P in ethyl acetate, 50 % w/w solution). In a representative kilo-lab procedure for a substituted biphenyl-2-amine coupling, the acid (1.0 eq), amine (0.98 eq), and pyridine (2.5 eq) are dissolved in ethyl acetate at 15 °C. T3P (1.3 eq) is added dropwise over 40 minutes, maintaining the batch below 25 °C. This method is preferred over mixed anhydride routes because it avoids the necessity to treat and dispose of the isobutyl chloroformate byproduct stream, aligning with the E-factor <15 targets mandated by the European Crop Protection Association’s product stewardship guidelines.

After aqueous workup with 1 M HCl and then 5 % Na₂CO₃ to eliminate residual propylphosphonic acid, the crude N-(biphenyl-2-yl)-4-isopropylthiazole-2-carboxamide is subjected to hot filtration through a 0.5 µm activated carbon pad to scavenge colloidal palladium carryover from an upstream Suzuki coupling that generated the amine fragment. Distillation to a minimum stirred volume and addition of methanol (3 volumes) induces crystallization; the slurry is cooled linearly at 0.3 °C/min to 2 °C to achieve a d₅₀ particle size of 80–120 µm — critical for re-dispersibility in adjuvant-loaded suspension concentrate formulations tested according to CIPAC MT 184. Drying at 45 °C under nitrogen sweep reduces loss-on-drying to <0.5 %.

For registration as a plant protection product building block under EU 1107/2009, the residual heavy metal profile is analyzed by ICP-MS: lead and cadmium must be ≤ 1 mg/kg, arsenic ≤ 0.5 mg/kg, and mercury ≤ 0.1 mg/kg, reflecting the soil ecotoxicology trigger values specified in SANCO/10387/2002 revision 10. Beyond the analytical compliance, the acute oral toxicity of the isolated intermediate is assessed per OECD 423, and an Ames test screening (OECD 471) is routinely requested by tier-1 buyers to rule out mutagenic impurities derived from the thiazole ring itself. The business-critical endpoint remains the four-week stability data at 54 °C (accelerated storage per CIPAC MT 46.3): the carboxamide content must not drop below 94 % w/w, with the primary degradation pathway being photo-Fries rearrangement to the ortho-aminophenone isomer, detectable at trace levels by UPLC-HRMS.

Field-trial quantities of the derived 250 g/L SC formulation are tank-mixed with epoxiconazole at 0.75 L/ha for Septoria tritici control in Northern European winter wheat, with the carboxamide acting as a succinate dehydrogenase inhibitor complementary to triazole DMI action — ensuring dual-site binding and delaying resistance emergence. The 4-isopropyl substitution on the thiazole scaffold was retained through SAR studies because it reduces log P by 0.3 units relative to the tert-butyl analogue, improving xylem mobility as determined by the petiole uptake assay adapted from the EPPO PP 1/239 guideline.

Can Low-Temperature Amide Coupling Prevent Decarboxylation During Peptide Conjugation?

Enzymatic esterification of 4-isopropylthiazole-2-carboxylic acid with anhydrous ethanol finds its place in process flavour manufacture, where the resulting ethyl ester (≥ 97 % purity, FCC-grade) delivers roasted cocoa, hazelnut, and light beefy top notes recognized by FEMA GRAS 4278 for the broader alkylthiazole family. The acid, pre-dried to <0.1 % water, is dissolved in methyl tert-butyl ether at 0.3 M and combined with 1.2 equivalents of ethanol and immobilized Candida antarctica lipase B (Novozym 435, 10 % w/w relative to acid). The slurry is agitated at 30 °C under molecular sieve-pressurized headspace (dew point ≤ −40 °C) for 12–18 hours to push the equilibrium above 85 % conversion. Filtration and solvent swap to triacetin yield a 1.0 % w/w stock solution that flavour houses incorporate at 0.05–0.2 % of the finished reaction flavour weight. Regulation (EC) No 1334/2008 Annex I listing must be checked for the specific ester because member-state interpretations vary, and a Certificate of Analysis referencing JECFA specifications for food flavourings (Volume 4, metallic impurities ≤ 2 mg/kg) is standard in export documentation.

Ligand Precursor for Asymmetric Transfer Hydrogenation — Steric Effects of the 4-iPr Group

Complexation with half-sandwich ruthenium(II) precursors converts the acid into a bidentate N,O-donor ligand suited for asymmetric reduction of prochiral ketones. In a Schlenk-line procedure, 2.2 equivalents of 4-isopropylthiazole-2-carboxylic acid are deprotonated with sodium methoxide (2.1 eq) in dry methanol at 25 °C, then added to [RuCl₂(p-cymene)]₂ (1.0 eq Ru). After 16 hours of reflux under argon, the precipitated NaCl is filtered off and the filtrate is concentrated to a brick-red solid. The crude bis(carboxylato) complex is triturated with diethyl ether and dried in vacuo to a chloride content ≤ 0.3 % w/w by potentiometric titration. Catalytic testing for the asymmetric transfer hydrogenation of acetophenone in isopropanol with KOH (5 mol %) at 60 °C typically achieves turnover frequencies of 450–600 h⁻¹ and enantiomeric excesses that parallel the 4-tert-butylthiazole ligand within ± 2 % ee (chiral GC, Cyclosil-B column, ASTM D 3257 reference conditions). The 4-isopropyl substituent reduces the extent of face selectivity erosion caused by rotational freedom of the carboxylate arm relative to smaller methyl analogs, a steric advantage maintained only at loadings below 1.0 mol % catalyst; higher loadings promote ligand disproportionation observed as a dark Ru(0) precipitate that fouls the reactor surface.